Salvia BioElectronics
PrivateLast Round
Series B
May 27, 2025
Total Funding Raised
$98.43M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Salvia BioElectronics is a medical device company that develops minimally invasive, ultra-thin implantable neuromodulation technology to treat chronic migraines and cluster headaches.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salvia BioElectronics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Salvia BioElectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2025 | ||||
| Debt | Sep 22, 2020 | ||||
| Series A | Sep 22, 2020 | ||||
| Seed | May 23, 2018 |
Key People
Founding team and executive leadership
Salvia BioElectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B |
| SHS Gesellschaft für Beteiligungsmanagement mbH | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B, Seed |
| Dolby Family Ventures | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B |
| Invest-NL | Series B |
| McPike Global Family Office | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Grew 16% QoQ, from 67 to 78 employees.
- Apr 23, 2026
Neuromodulation therapy for chronic migraine is currently being evaluated in clinical studies.
Salvia BioElectronics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Salvia BioElectronics's valuation, stock price, and market status.